HDAC1 and craniodiaphyseal dysplasia: The primary finding of this study is that EGCG may be an effective agent for preventing aging-related CDD and cTnI expression decline by inhibiting HDAC1 and increasing AcH3 and AcH3K9 near cTnI's promoter in aged mice (Fig. 6).